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Summary 
Expression of microRNA (miRNA) in developing murine tissues was studied: focus being on 
the miR-17-92 cluster (oncomir-1) and two paralogous clusters, miR-106a-363 and miR-
106b-25. Using microarrays we mapped the miRNA expression profile at selected times 
during development of two oral tissues: tooth germ and submandibular salivary gland. 
MiRNA expression in developing liver was also monitored. MiRNA expression was found to 
be highly abundant during development of these tissues: five of the miRNAs encoded in the 
miR-17-92 cluster exhibited decreased expression at postnatal stages compared to embryonic 
stages (Paper I). 
Despite the oncogenic role of the miR-17-92 cluster, the function of the cluster in 
normal tissue remains unclear. However, studies have implicated the miR-17-92 cluster in 
development, and the cluster may be involved in regulation of cell cycle. The miR-106b-25 
cluster has been associated with analogous functions. 
Expression of the miR-17-92 primary transcript and all miRNAs encoded in this cluster 
was measured in nine different murine tissues at various developmental stages using real-time 
PCR. The relative levels of expression all miRNAs encoded in the miR-17-92 cluster 
exhibited decreased expression during development. Moreover, the pattern of expression of 
the primary transcript correlated to that of the mature miRNAs, although, the level of 
expression of the individual miRNAs were markedly different. These observations indicate 
that the level of expression of miRNAs encoded in the miR-17-92 cluster is regulated at a 
post-transcriptional level. To investigate possible involvement of members of the miR-17-92 
cluster in proliferation the levels of expression of all members of the cluster were monitored 
at selected cell passages of cultured primary oral keratinocytes. The results indicate miRNAs 
of the miR-17-92 cluster may promote cell proliferation and inhibit differentiation (Paper II). 
Possible functions of the members of the miR-106a-363 cluster, often considered as 
non-functional, was investigated by transfecting cells with miR-363* mimic. Transfection 
with miR-363* mimic led to decreased cellular proliferation and to decreased levels of 
expression of all miRNAs encoded by the miR-17-92 and miR-106b-25 clusters, suggesting 
that miR-363* may exert an inhibitory effect on expression of miRNAs derived from 
paralogous clusters. Therefore, the results suggest that the miRNAs*-species are not always 
by-products devoid of biological function (Paper III).  
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1 Introduction 
1.1 What are microRNAs? 
It has been assumed that biological processes are primarily controlled by regulatory proteins. 
However, the number of protein-coding genes in a genome is not correlated to the complexity 
of the organism. In fact, about 98% of transcriptional output in humans is non-protein-coding 
RNA [1]. These sequences have been considered to be evolutionary “garbage” without any 
function. During the last decade, however, a significant fraction of this non-coding RNA has 
been suggested to be highly relevant for the regulation of gene expression [2]. Strong 
association between the amount of non-coding sequences and biological complexity has also 
been found [1]. Therefore, an additional layer of regulatory RNA has been revealed (Fig. 1). 
Non-coding RNAs are suggested to act as a digital processing network, allowing increased 
regulatory complexity in biological systems, well beyond that achieved by protein-based 
analog regulatory networks [1]. One group of highly abundant and functionally important 
non-coding RNAs is microRNAs (miRNAs). MiRNAs are found in all eukaryotic cells [3]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1. The flow of genetic information from DNA to protein is regulated by a network of interactions 
involving RNA molecules. 
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1.1.1 The discovery of microRNAs 
MiRNAs were discovered in 1993 by Victor Ambros and colleagues during their study of the 
gene lin-14 in C. elegans. Ambros and his colleagues cloned the gene for lin-4, a repressor of 
lin-14. The lin-4 gene product turned out to be a short (~ 22-nucleotide), non-coding strand of 
RNA, containing sequences partially complementary to multiple sequences in the 3’UTR of 
the lin-14 mRNA. The researchers reported that this new “small antisense” lin-4 RNA was 
capable of down-regulating gene expression by directly binding the lin-14 mRNA [4].  
Ambros et al. found that lin-4 regulated not only lin-14 but also lin-28, suggesting that 
miRNA functioned at multiple sites across the C. elegans genome [5]. 
Until the beginning of 2000 the discovery of the first miRNA was barely noticed by the 
scientific community. In 2000, Ruvken and colleagues discovered a second miRNA in C. 
elegans, let-7, whose sequence was shown to be evolutionarily conserved across the animal 
kingdom [6, 7]. These findings were the beginning of the small RNA revolution. 
1.1.2 Biogenesis and basic functions of microRNAs 
The biogenesis of miRNAs in animals was described by Bartel et al. in 2004 [8].  
Transcription of miRNAs is regulated in a manner similar to that of protein-coding genes. 
About 40% of miRNA loci are located in the intronic region of non-protein coding transcripts 
and about 10% in the exonic region of non-protein coding sequences, ~40 % appear in the 
exonic region of protein-coding genes [9]. Transcription by polymerase II (or polymerase III) 
generates long primary transcripts (pri-miRNA) several kilo bases in length that are capped 
and polyadenylated (Fig.2) [8-10]. The primary transcripts may contain mono-cistronic or 
poly-cistronic hair-pin structures with ~32 nucleotides (nt) long imperfectly base-paired stems 
and terminal loops [11, 12]. The monocistronic transcripts encode individual miRNAs, while 
the poly-cistronic transcripts encode a number of coordinately expressed miRNAs, so called 
miRNA clusters [11, 13]. There are normally two or three miRNA genes in a cluster, 
however, larger cluster also exist [10].  
The evolutionary conserved mechanism by which pri-miRNA are processed initially to 
precursor miRNAs (pre-miRNAs) and subsequently to mature miRNAs involves two 
endonucleolytic cleavages by the RNase III enzymes Drosha and Dicer [14, 15]. Drocha 
processes the pri-miRNA into a ~70 nt hairpin pre-miRNA. Subsequently, the pre-miRNA is 
transported into the cytoplasm through interaction with exportine-5 and Ran-GTP, where it 
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undergoes a second round of processing, this time catalysed by Dicer [15, 16]. The product is 
a ~22 nt miRNA:miRNA* duplex. Both Drocha and Dicer are assisted by a number of 
cofactors or accessory proteins, some of which have regulatory functions. The levels and 
activity of these proteins control the accumulation of miRNAs (e.g. DGCR8, TRBP) [14].  
Epigenetic events, such as promoter methylation and histone acetylation, have also 
been shown to alter the miRNA expression. However, the interaction between microRNAs 
and the epigenetic machinery is complicated by the fact that microRNAs also target 
molecules involved in the methylation and acetylation of DNA and histones, therefore, also 
likely regulating these mechanisms [17].  
One strand of the ~22 nt duplex (the miRNA or the miRNA*) is subsequently 
incorporated into the miRNA-induced silencing complex (miRISC) by associating with 
Argonaute (AGO) proteins [3, 14]. It was formerly assumed that the miRNA strand is selected 
for entry into miRISC, and that the miRNA* strand is degraded. However, recent studies has 
pointed out that the miRNA* species may have physiological roles [3].  
The miRISC uses the retained miRNA as a guide strand to identify target mRNAs, and 
miRNAs regulate protein synthesis by base-pairing to target mRNAs [14]. The 
complementary canonical base-pairing between the “seed” sequence of the miRNA 
(nucleotides 2-8 at its 5’-end) and its complementary seed match sequence (which is present 
in the 3’-UTR of target mRNAs) determine the extent of inhibition of the target [3]. Perfect or 
near-perfect complementarity is required for mRNA cleavage; lower degrees of 
complementarity will lead to repression of protein synthesis. In animals, the latter mechanism 
is more common [3]. Endonucleolytic cleavage of the target mRNA is usually prevented by 
mismatches and bulges in the central region of the miRNA-mRNA duplexes [18].  
The miRNA repress protein synthesis either by repressing translation and/or by bringing 
about deadenylation and subsequent mRNA decay [14, 19]. Several mechanisms have been 
proposed for the repression of protein synthsis by miRNAs, including inhibition at the level of 
initiation or elongation, as well as storage of mRNAs in P-bodies and SGs (stress granules) 
[14, 18]. Lately, multivesicular bodies (MVBs) and endosomes have also been recognized as 
cellular organelles that contribute to miRNA function [18]. The principal model is that 
translational inhibition leads to mRNA degradation in the absence of mechanism able to 
protect the transcript. However, the connection between translational inhibition and decay 
remains to be fully understood. 
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The “seed” sequence tends to be the most highly conserved region of a miRNA molecule 
[20]. Consequently, miRNAs are often grouped into families based on the “seed” sequence 
[21]. By means of the “seed” sequence, bioinformatic target prediction suggests that human 
miRNAs could potentially regulate up to 50% of the protein-coding genes in the human 
genome [14]. However, the significance of the “seed” sequence has been contradicted by 
studies showing the that sequences outside the “seed” are also crucial for gene regulation 
[22]. In animals, there is also growing evidence that binding of miRNAs within the 5’-UTR 
and coding regions of the target mRNA can lead to post-transcriptional control [23]. 
Additionally, a single miRNA molecule may have multiple effects because of its ability to 
regulate several targets [14]. On the other hand, several miRNAs can target the same mRNA, 
thereby modulating the effect of a single miRNA in a combinatorial manner. 
Lately, a wide variety of mechanisms has been shown to generate miRNA-like molecules.  
Bypassing a key step involved in the canonical miRNA pathway, mitron, snoRNA, shRNA or 
tRNA have been suggested to yield subclasses of miRNAs. Consequently, non-canonical 
pathways of miRNA biogenesis presents an additional level of complexity to the miRNA-
dependent regulation of mRNA expression (reviewed in  [12]). 
MiRNA may also have functions other than translational gene silencing. Several reports 
indicate that miRNAs act as activators of translation [14, 18]. In addition, mature mammalian 
miRNAs can be imported into the nucleus suggesting that miRNAs regulate transcription 
(Fig.2) [24]. Recent finding suggests that exosomes containing miRNAs can be transferred 
from one cell to another. These results indicate that miRNA plays a regulatory role in 
paracrine signaling, and imply potential transfer of genetic information between cells [25]. 
Overall, miRNAs have been found in tissues, serum, plasma and other body fluids such as 
urine and saliva [25-27].  
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Fig.2 MicroRNA biogenesis. MiRNAs are processed by Drocha and Dicer with additional cofactors 
in the nucleus and cytoplasm, respectively, prior to being loaded into the RISC complex. The miRNA 
guides the RISC complex to target mRNA repressing protein synthesis either by repressing translation 
or mRNA degradation.  
Reprinted from New Eng. J. Med., vol. 353, no. 17, pp. 1768-1771, Chen (2005), MicroRNAs as Oncogenes and 
Tumor Suppressors, with premission from New England Journal of Medicine. 
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1.1.3 MicroRNA clusters 
Many miRNAs are encoded as polycistronic clusters [13]. Studies indicate that up to 50% of 
discovered miRNAs are encoded in this manner [11]. Functions of clustered miRNAs and 
their evolutionary origin remain unclear. However, there are indications that miRNA clusters 
are produced through tandem – and segmental gene duplication accumulating as a 
consequence of natural selection. These duplications have resulted in partially paralogous 
miRNA clusters located on different chromosomes [10].   
MiRNA clusters are generally composed of two or more associated miRNAs encoded 
within a single RNA transcript [10, 28]. They frequently share sequence similarity and are co 
expressed with host genes [10, 11]. The members of a single miRNA cluster can be 
consistently expressed or differentially expressed. The mechanism underlying such variable 
expression is unknown. 
MiRNA clusters frequently contain representatives from different miRNA families, 
meaning that miRNAs of a given cluster target multiple mRNAs. It has also been proposed 
that mRNA transcripts encoding co operating proteins, e.g., proteins involved in the same 
pathway, are typically targeted by miRNAs from the same polycistronic cluster [29]. 
Moreover, clustered miRNAs may regulate complex gene networks and signaling pathways, 
as more precise regulation is achieved by polycistronic clusters compared to individual 
miRNAs [10]. 
1.1.4 MicroRNAs in development 
MiRNAs play an essential role in embryonic and tissue development [30]. Also, the 
expression of some mammalian miRNAs are tissue specific [31]. In ES (embryonic stem) 
cells, miRNAs have been implicated in sustaining cell identity. Later in development, miRNA 
are expressed in a dynamic fashion, often showing selective expression in differentiating cells 
[32-34].  
The importance of miRNAs in development has been tested using Dicer knock-out mice. 
Dicer is essential for miRNA processing [35], and, therefore, a Dicer-deficient animal is 
unable to synthesis new miRNAs. Dicer deficient embryos die at an early embryonic stage 
and are depleted of pluripotent stem cells, supporting the crucial role for miRNA in 
embryogenesis and stem cell development [35, 36]. In all plant and animal species examined, 
defects in miRNA function have profound effects on development [37].  
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MiRNAs have been shown to regulate heart, brain, liver and muscle development, as well 
as organogenesis of skin and lung [36] [38] [31]. Specific roles of miRNAs have also been 
characterized in hematopoiesis [39].  
1.1.5 MicroRNAs in disease 
In view of the essential regulatory function of miRNAs [14, 40]; it is not surprising that 
miRNAs have been found to be involved in the pathogenesis of several diseases. For example, 
miRNAs are aberrantly expressed in cardiovascular disease, neurodegenerative disease (e.g. 
Alzheimer’s disease), diabetes, kidney disease, and infectious disease [41-43]. Comparison of 
microRNA expression profiles in diseased and healthy tissue has shown the pathological state 
to be associated with altered expression of miRNAs [36].  
MiRNAs have also been reported in several types of cancer [44]. Evidence indicates that 
miRNAs can function as tumour suppressor- or oncogenes, such miRNAs are called 
“oncomirs”. If a target gene is an oncogene, loss of a corresponding miRNA, which function 
as a tumour suppressor, may cause synthesis of oncoprotein leading to tumour development 
[44]. On the other hand, amplification and overexpression of miRNAs functioning as 
oncogenes may cause translational inhibition of tumour suppressor mRNAs, also inducing 
tumour genesis. Many transcription factors regulate miRNA expression, and expression of 
some miRNAs are regulated by well-established tumour suppressor- or oncogenes, e.g. TP53, 
MYC and RAS [14, 16]. 
The abnormal expression of miRNA in different diseases may be caused by mutation in 
miRNA encoding genes or aberrant miRNA biogenesis. Therefore, miRNAs may serve as 
useful biomarkers [44]. Moreover, miRNAs could also serve as an alternative therapeutic 
target. A promising approach is to target disease-related miRNAs using anti-miRNA oligos 
(miRNA inhibitors) to knock-down overexpressed miRNAs. Another technique is systemic 
delivery of miRNA mimics for up-regulation of a selected miRNA [45]. New advances in 
delivery of miRNA inhibitors and mimics hold the promise of quickly translating our 
understanding of miRNA into useful therapy [44]. 
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1.1.6 Techniques for studying microRNAs  
MiRNAs can be studied using different approaches. An essential stage is the selection of 
which assay to use. Expression profiling is carried out using microarrays or deep sequencing 
[46, 47]. While microarrays have the ability to measure thousands of already sequenced 
genes, profiling of miRNAs by deep sequencing measures total abundance and allows for the 
discovery of new miRNAs [48]. Northern blotting, real-time PCR and in situ hybridization 
can be used to assay levels of individual miRNAs [46]. 
 
The list of known miRNAs is large and increasing. However, only a few regulatory 
targets are known. Prediction and validation of target mRNAs are necessary in understanding 
miRNA biology. Therefore, bioinformatic target prediction is often the first step towards 
defining function for a specific miRNA. Several computational methods and databases have 
been developed for this purpose (e.g. MiRanda, Target Scan and PicTar) [49]. Computational 
approaches are based mainly on miRNAs complementarity to their target mRNAs. Although 
target prediction criteria may differ, three principles are often involved: strong Watson-Crick 
base pairing of the “seed” sequence of the miRNA to a complementary site in the 3’UTR of 
the mRNA, conservation of the miRNA binding site, and the minimum free energy (MFE) of 
the miRNA-mRNA hetroduplex. Also, mRNA sequence features outside the target site can be 
significant, e.g. a good structural accessibility [49]. Based on theoretical considerations, a 
miRNA can have several hundred targets [50].  However, the resulting output of targets will 
depend on the algorithms used, and comparison of results from different algorithms is often 
useful. 
 
Genes regulated by a miRNA may be identified using transcriptosome and proteome 
analysis. Verification of a miRNA target site can be performed by in vitro 3’ UTR analysis. 
The functional relevance of a miRNA is best investigated by monitoring phenotypic changes 
in cultured cells or within an organism in response to changes in levels of a miRNA, so called 
reverse genetics [49]. Strategies for gain- and loss-of-function studies for specific miRNAs in 
vivo and in vitro have been developed. These studies include transfection experiments with 
miRNA mimics or anti-miRNAs, as well as transgenic animal models [45]. Thus, a 
combination of reverse genetics and computational prediction is useful when studying 
miRNA functions [49]. 
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1.2 Why study microRNA expression during development 
of oral tissues? 
To gain insight into the functional role of miRNAs during development it is necessary to 
accumulate information on their temporal and spatial expression. From studies of tissue- or 
cell-specific miRNA profiles, it may be possible to recognize miRNAs exhibiting prominent 
selective expression during proliferation, differentiation, maturation or apoptosis. 
By studying this new layer of gene regulation in both in vivo and in vitro systems we can 
improve our understanding of the underlying molecular mechanisms of miRNAs. This 
knowledge can give an opportunity to further expand our understanding of molecular 
processes occurring both during normal and abnormal development. 
The development of ectodermal organs such as scales, feathers, hairs, glands and teeth, is 
regulated by a complex dialog between and within epithelial and mesenchymal tissues [51]. 
At the start of this dissertational work, miRNAs had been shown to regulate skin 
morphogenesis [52], hair production [53], and mammary gland formation [54], but there were 
no published studies on miRNA expression in craniofacial organs such as teeth. MiRNA 
expression in oral tissues had not been address.  
 The development of oral tissues, e.g. teeth and salivary glands, involves several 
morphologically distinct stages, each controlled by genetic interactions involving growth 
factors, transcription factors, signal receptors and diffusible morphogens [51, 55]. Developing 
murine tooth and salivary gland, therefore, provide good models for studying miRNA 
expression during organogenesis. The major disadvantage of using the murine model is the 
small mass of collectable tissue and the consequently limited amounts of RNA which can be 
isolated. 
The initial investigation of miRNA expression profiles required large scale microarray 
analysis. The first challenge was, therefore, to establish a protocol that could measure several 
hundred miRNAs using limited amounts RNA.  
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1.3 The miR-17-92 cluster 
The results of our first study directed our attention to the members of the miR-17-92 cluster 
(Paper I). The miR-17-92 cluster is a polycistronic miRNA cluster located on chromosome 13 
open reading frame 25 (C13orf25) in the human genome and on chromosome 14 in the mouse 
genome [56-58]. The primary transcript includes six tandem stem-loop hairpin structures that 
give rise to six mature miRNAs: miR-17, miR-18a, miR-19a, miR-20a, miR-19b-1, and miR-
92a-1 (Fig.3). These are encoded within an 800 base-pair region in the human genome [59]. 
The six miRNAs can be grouped into four miRNA families based on their seed sequence: the 
miR-17 family (miR-17 and miR-20a), the miR-18 family (miR-18a), the miR-19 family 
(miR-19a and miR-19b-1) and miR-92 family (miR-92a-1) [13, 57]. The oncogenic potential 
of miR-17-92 cluster was first described by He et al. The miR-17-92 cluster was the first 
oncogenic miRNA cluster identified and was named oncomir-1 [58].   
The promoter region of miRNA encoding genes is highly analogous to those of protein-
coding genes [9, 14]. The primary miR-17-92 transcript initiates from a consensus initiator 
sequence downstream of a nonconsensus TATA box [60]. In vertebrate genomes, a sequence 
upstream of the assumed transcriptional start site is highly conserved and contains an 
extensive CpG island, indicative of a core promoter region. Several transcription factors have 
been identified as activators of the miR-17-92 cluster; STAT3, c-Myc, n-Myc and E2F1 and 
E2F3 [60, 61]. Studies have also revealed that transcription of the cluster is repressed by p53 
[57, 61]. 
The oncogenic potential of the miR-17-92 cluster has been observed both in human 
tumours and in animal models. The human genomic locus encoding these miRNAs, 13q31.3, 
undergoes amplification in lymphomas and solid tumours [57]. The murine miR-17-92 cluster 
is also a common insertion site in multiple types of retrovirally induced leukemia’s [57].  
However, in ovarian-, breast and skin cancer the cluster is deleted [62].  
A complex interacting network comprising of Myc, E2F and the miR-17-92 cluster has 
been unraveled. The oncogenic function of the miR-17-92 cluster enables DNA-damaged 
cells to escape apoptosis [63]. The proliferative effect of the cluster can be partly due to miR-
17 and miR-20 targeting the cyclin-dependent kinase inhibitor CDKN1A (p21) [61, 63].  
Until recently it was unknown whether the oncogenic potential of the miR-17-92 cluster 
was caused by all components of the cluster or by a single member. However, recent reports 
have demonstrated that miR-19 is the major oncogenic constituent of the cluster in vivo and 
that the tumor suppressor PTEN is the major target of miR-19 [57, 61].  
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Members of the miR-17-92 cluster belong to different miRNA families and it is likely that 
they target unrelated mRNAs [59]. Therefore, a wide range of miRNA-mRNA interactions is 
possible, and consequently these interactions may result in substantial regulatory complexity. 
Mouse knock-out studies have shown members of the miR-17-92 cluster to possess specific, 
yet overlapping, functions [57]. So far, around 30 mRNAs targeted by members of the miR-
17-92 cluster have been experimentally verified, including E2F1, Bim, HIF-1α and TNF-α. 
These genes encode proteins which are involved in regulation of cell cycle or apoptosis [61, 
64]. However, the oncogenic effects of the members of miR-17-92 are probably mediated by 
regulation of multiple mRNA targets, many of which remains to be discovered. 
Even though the miR-17-92 cluster has a well-known role in carcinogenesis, its 
physiological function remains uncertain. In 2007, Lu et al. demonstrated that the members of 
the miR-17-92 cluster are highly expressed in mouse embryonic lung and that the level of 
expression decreases as mice approaches maturity. The results also suggested that miR-17-92 
promotes proliferation and inhibit differentiation of lung epithelial progenitor cells [38]. In a 
study by Ventura et al. loss-of –function of the miR-17-92 cluster caused postnatal death. The 
study also showed that the miR-17-92 cluster has a critical role during development of lung 
and heart [65].  
Because of the documented role for the miR-17-29 cluster in development of lymphoma, 
lymphocyte development was studied in mice either lacking or overexpressing the miR-17-92 
cluster. Several studies have suggested the cluster to be involved in development of B cells, T 
cells and monocytes. It has been suggested that the miR-17-92 cluster is essential for the 
survival signaling regulating progression from the pro-B cell to the pre-B cell stage. However, 
other hematopoietic cells, e.g., erythrocytes, monocytes, and T-cells are not affected by loss 
of these miRNAs. On the other hand, overexpression of the miR-17-92 cluster in lymphocytes 
in vivo leads to B-cell and T-cell proliferation and survival. The two tumor suppressors, Bim 
and PTEN, were identified as targets. The miR-17-92 cluster also controls monocyte 
development by inhibiting monocyte differentiation and maturation (reviewed in [62]). 
In conclusion, the miR-17-92 cluster is commonly expressed in a variety of cell types and 
tissues, and effects of the miRNAs encoded in the miR-17-92 cluster will likely depend on the 
cellular context. However, pleiotropic effects of the miR-17-92 cluster remains unclear.  
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1.4 The miR-106a-363 and miR-106b-25 clusters 
Ancient gene duplications have given rise to two miR-17-92 paralogs in mammals; the 
polycistronic miR-106a-363 cluster located on the X chromosome and the polycistronic miR-
106b-25 cluster located on chromosome 5 in mice and chromosome 7 in humans [13, 59]. 
Each of these clusters contains miRNAs which are homologues to a subset of those of the 
miR-17-92 cluster [65]. The organization of miRNAs within these paralogs is conserved, and 
the sequence of each constituent miRNA is highly conserved across species [66]. Together, 
these three clusters contain 15 miRNA stem-loops, giving rise to 13 distinct mature miRNAs 
which belong to four miRNA families: the miR-106 family (miR-106a, miR-106b, miR-93, 
miR-17, miR-20a and miR-20b), the miR-18 family (miR-18a and mir-18b), the miR-19 
family (miR-19a, miR-19b-1 and miR-19b-2) and the miR-92 family (miR-92a-1, miR-92a-2, 
miR-25 and miR-363) (Fig. 3) [59, 65]. 
The miR-106-363 cluster lies directly at the 3’-end of the non-coding sequense Kis2 in 
mouse [56]. The cluster encodes six miRNAs: miR-106a, miR-18b, miR-19b-2, miR-20b, 
miR-92a-2 and miR-363 (Fig.3) [65]. The miR-106b-25 cluster is located in the intron 13 of 
the host gene MCM7 in both humans and mouse, and are composed of three miRNAs: miR-
106b, miR-93 and miR-25 [59, 66] (Fig.3). MCM7 is essential for the initiation of DNA 
replication in eukaryotes. MCM7 is transcriptionally regulated by E2F1 and MYC [63]. 
The miR-17-92 and miR-106b-25 clusters are abundantly expressed in many cell- and 
tissue types, while expression of the miR-106a-363 cluster is undetectable in most normal 
tissue examined [59, 66]. However, all three clusters are considered oncogenic and have been 
found to be up-regulated in various types of cancers [56, 66]. MCM7 and the miR-106b-25 
cluster have been shown to co operate in tumour genesis, suggesting a functional interaction 
between an intronic miRNA and its host protein [66]. Thus, a single gene locus can have two 
independent and co operating oncogenic elements. 
Given their sequence similarity, the three clusters are predicted to have highly overlapping 
targets. The miR-17-92 and miR-106b-25 clusters seem to be involved in analogous cellular 
functions such as the control of the cell cycle and TGFβ signaling [66]. E2F1 regulates the 
expression of both the miR-106b-25 and miR-17-92 clusters [60, 63, 67]. On the other hand, 
members of the miR-106b-25 and miR-17-92 clusters regulate E2F1 directly through a highly 
conserved binding site in its 3’-UTR [60]. In this manner a negative feedback loop between 
miR-106b-25/miR-17-92 and E2F1 is created (Fig.5) [63]. Also, miR-17, miR-20a, miR-106b 
and miR-93 repress p21 expression, whereas miR-92 and miR-25 inhibit BIM expression, 
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suggesting that members of the miR-106b-25 and miR-17-92 clusters inactivate the TGFβ 
pathway in a co-operative manner [57, 66].  
Ventura et al. showed that levels of expression of the miR-17-92 and miR-106b-25 
clusters are similar in mouse tissues [65]. However, only the miR-17-92 cluster is required for 
normal development, while the miR-106b-25 cluster appears to be dispensable. One possible 
explanation for this observation could be the difference between the two clusters; the miR-17-
92 cluster encodes three miRNAs, miR-18a, miR-19a and miR-19b, which are not encoded in 
the miR-106b-25 cluster. Interestingly, a double knockout of both the miR-106b-25 and miR-
17-92 clusters resulted in a more severely lethal phenotype, suggesting an additive effect of 
the miR-106b-25 cluster [59].  
Li et al. showed that inhibition of expression of the miR-106 family contributes to typical 
features of senescent cells, e.g. increased resistance to apoptosis and activation of p21 [68]. 
While increased expression of miR-106a enhanced cellular proliferation, inhibition of miR-
106a expression had no significant effects. The authors suggested that mechanism 
compensating for the loss of miR-106a could be present, e.g. a mechanism involving other 
members of the miR-106 family. So far, several targets for the miR-106 family have been 
experimentally verified, e.g. E2F1, Rbl2, BIM, p21, Mapk14 and Stat3 [61]. 
While several studies have focused on the expression and function of the miR-17-92 and 
miR-106b-25 clusters, the expression and function of the miR-106a-363 cluster remains 
unclear.  
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Fig.3. The genomic organization and primary transcripts of the human and mouse miR-17-92, miR-
106a-363, and  miR-106b-25 clusters. Based on their seed sequences the miRNAs of these clusters can 
be grouped  into four families: the miR-106 family (miR-17, miR-20a/b, miR-106a/b, and miR-93) 
(blue); the miR-18 family (miR-18a/b) (yellow); the miR-19 family (miR-19a/b-1/2) (red); and the 
miR-92 family (miR-25, miR-92a-1/2, and miR-363) (green). 
 
 
 
 
 
- 25 - 
 
2 Study aims 
The major aim of this thesis was to study miRNA expression during tissue 
development in mice. Such studies should reveal differences in expression profiles, perhaps 
providing a guide to their function. 
 
The specific aims were:  
 
1) Establish the miRNA expression profiles for two oral tissues; the murine molar tooth 
germ and the murine submandibular salivary gland during development (Paper I). 
 
2) Investigate the levels of expression of the primary transcript and all mature members 
of the miR-17-92 cluster in a range of murine embryonic/young adult tissues, and 
cultured human oral keratinocytes, and cultured human squamous carcinoma cells 
(Paper II). 
 
3) Investigate the level of expression of the primary transcripts and all matured members 
of the miR-17-92, miR-106a-363 and miR-106b-25 clusters following transfection of 
miR-363* mimic in cultured human squamous carcinoma cells (Paper III). 
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3 Summary of results 
3.1 MicroRNA expression in developing murine tooth, 
salivary gland, and liver (Paper I) 
A total of 112 different miRNAs were detected in developing murine tooth, salivary gland 
and liver. The expression profiles of 76 miRNAs detected in tooth germ at E15.5, P0 and P5 
were established, together with the expression profile for the 88 miRNA found in 
submandibular salivary gland (SMG) at E15.5, P0, P5 and P25.  
To validate the results, liver was used as a control tissue. This screening led to the 
identification of 82 miRNA expressed in liver, 48 of which were expressed at both time points 
investigated (E15.5 and P25). Several of these miRNAs had earlier been identified in mouse 
liver [69]. Also, 15 miRNAs appeared tissue-specific. 
Among the 112 miRNA identified, 52 miRNAs were detected in all tissues examined. 
Among these, five of the members of the miR-17-92 cluster were identified (miR-17, miR-
18a, miR-19b, miR-20a and miR-92a).  The result revealed these miRNAs to be highly 
expressed in embryonic tissues and that their expression decreased during development. 
 
3.2 Expression of the members of the miR-17-92 cluster in 
developing murine tissues (Paper II) 
Microarray results obtained for miR-17, miR-18a, miR-19b, miR-20a and miR-92a were 
verified using real-time PCR. The data were further extended with additional tissues (lung, 
kidney, heart, brain (cerebral hemisphere), skin and small intestine) to investigate whether the 
pattern of expression of the members of the miR-17-92 is tissue specific or universal. The 
real-time PCR results showed that all members of the miR-17-92 cluster exhibited decreased 
expression at a postnatal stage (P25) compared to embryonic stages (E13.5 and E15.5). 
To further extend mapping of expression of members of the miR-17-92 cluster, liver, 
lung and SMG were selected for additional analysis. The miR-17-92 cluster already had an 
established role in lung development [38], while the role of the cluster in liver and SMG was 
unexplored. The expression of all members of the miR-17-92 cluster was, therefore, measured 
across a selected range of developmental time-points in the three tissues (E11.5, E13.5, E15.5, 
E17.5, P0, P5 and P25). 
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In liver, the expression of all members of the cluster decreased with increasing time of 
development. Also, in the SMG reduced expression with progressive development is a 
common trait for all members of the miR-17-92 cluster. However, the pattern of expression 
observed in lung was somewhat different from that found in liver and SMG. In lung, the 
lower level of expression for miR-19b, miR-20a and miR-92a are found at E11.5, P0 and P25. 
The higher level of expression was found at E13.5 and E15.5. Interestingly, miR-17 show a 
higher and more stable level of expression in embryonic lung compared to the other two 
tissues.  
Finally, the levels of expression of all members of the cluster were monitored in 
mouse embryos at E8.5 and E11.5. The results suggested that the level of expression of five 
(miR-17, miR-18a, miR-19a, miR-19b and miR-20a) of the six miRNAs was increased at 
E11.5 compared to E8.5, while that of miR-92a was significantly decreased. 
 To investigate whether the miR-17-92 cluster exhibited similar patterns of expression 
in embryonic tissues and in carcinoma cells we monitored the level of expression of all 
members of the cluster at selected passages of cultured, human squamous carcinoma cells 
(E10). In cultured carcinoma cells no decrease in expression was observed between P6, P15 
and P25. Rather, there was a significant increase in levels of expression.  
Further, to illustrate a potential association between proliferation and expression of 
miRNA encoded in the miR-17-92 cluster, we also measured expression of all members of the 
cluster in cultured, primary oral keratinocytes at selected passages. In two out of three 
cultures examined a consistent decrease in levels of expression of all members of the miR-17-
92 cluster was observed at the higher cell passage number. Overall, levels of expression of 
individual miRNAs in cultured keratinocytes were more like those found in intact tissue. 
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3.3 Expression of the miR-17-92 primary transcript in 
developing murine tissues (Paper II) 
The miR-17-92 cluster is a poly-cistronic transcript containing six miRNAs that are 
coordinately expressed, although the levels of resulting mature miRNAs differ. To investigate 
whether the level of expression of the primary miRNA transcript reflects that of the resulting 
mature miRNAs we measured the level of expression of the primary transcript, pri-miR-17-
92, in mouse liver, lung and SMG, and in cultured human primary oral keratinocytes and 
cultured human oral squamous carcinoma cells at various time-points/cell passages.  
To this end both pri-miR-17 (5’-flank of the gene) and pri-miR-92a-1 (3’-flank of the 
gene) were measured using real-time PCR. Mir-17, miR-18a, and miR-19a are located 
towards the 5’-flank of the gene, while miR-19b, miR-20a, and miR-92a are located towards 
the 3’-flank of the gene. The level of the primary transcript decreased during development in 
all tissues examined, and no significant differences between the 5’- and 3’-end were observed. 
In general, the level of expression of the primary transcript correlates with the expression of 
the matured miRNAs. The same correlation was observed with cultured human primary oral 
keratinocytes. 
In cultured human squamous carcinoma cells (E10) no significant increase between 
P6, P15 and P25 were observed. The level of expression of the primary transcript and those of 
resulting corresponding miRNA do not, therefore, correlate in carcinoma cells.  
 
3.4 Regulation of expression of microRNAs encoded by 
paralogous polycistronic clusters (Paper III) 
The three paralogous clusters miR-17-92, miR-106a-363 and miR-106b-25 collectively give 
rise to 15 mature miRNAs (miR-106a, miR-106b, miR-17, miR-18a, mir-18b, miR-19a, miR-
19b-1, miR-19b-2, miR-20a, miR-20b, miR-25, miR-92a-1, miR-92a-2, miR-93 and miR-
363). All of these 15 miRNAs have an accompanying star stand species considered as a 
passenger strand. However, star strand miRNAs have lately been shown to be of regulatory 
relevance [70]. When screening cultured human oral keratinocytes, high levels of expression 
of the star strand species of miR-363, miR-363*, were observed. On the other hand, miR-
363* was barely detectable in cultured human oral squamous carcinoma cells (E10). To 
investigate the function of miR-363* we, therefore, transfected E10 cells with miR-363* 
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mimic or scrambled control. The results showed decreased density of E10 cells and formation 
of cell colonies. 
Microarrays were used to monitor the miRNA expression in E10 cells transfected with 
miR-363* -, miR-19a -, miR-20b mimic or scrambled control. In cells transfected with miR-
363* mimic 27 miRNAs exhibited significantly lower level of expression. Only one miRNA 
molecule displayed significant increase: miR-485_5p. With miR-19a - or miR-20b mimic the 
majority of miRNAs affected showed increased level of expression. 
Both the microarray and the real-time PCR results show that the level of expression of all 
members of the miR-17-92 cluster was decreased in cells transfected with miR-363* mimic 
compared to scrambled control. Also, all members of the miR-106b-25 cluster exhibited 
decreased levels of expression in the cells transfected with the miR-363* mimic compared to 
scrambled control. However, miR-106a was the only detectable member of the mir-106a-363 
cluster in E10 cells. The level of expression of miR-106a was significantly decreased in cells 
transfected with miR-363*-mimic. In cells transfected with miR-19a, miR-20b and miR-92a 
mimics, effects on levels of expression of the different mature members varied depending on 
the mimic used. 
Real-time PCR was used to measure levels of expression of the miR-17-92, miR-106a-
363 and miR-106b-25 primary transcripts following transfection of miR-363* -, miR-19a -, 
miR-20b -, or miR-92a mimic, or scrambled control. Assays selective for pri-miR-17, pri-
miR-106a or pri-miR-106b (5’-flank of the gene), and pri-miR-92a-1, pri-miR-92a-2 or pri-
miR-25 (3’-flank of the gene) were used.  
The level of expression of the miR-106b-25 cluster was 5-6-fold higher than that of 
the miR-17-92 cluster. For both clusters the assays based on the 3- end constantly showed 
much higher levels of expression compared to the 5’-end. The miR-106a-363 cluster was not 
detectable. In cells transfected with miR-363* mimic the level of expression of the miR-17-92 
and the miR-106b-25 primary transcripts were significantly decreased. In cells transfected 
with miR-19a -, miR-20b -, or miR-92a mimic the level of expression of the miR-106b-25 
primary transcript was increased. The level of expression of the miR-17-92 primary transcript 
was increased in cells transfected with miR-19a mimic, while no significant change in 
expression were observed in cells transfected with miR-20b - or miR-92a mimic.  
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4 General discussion 
4.1 Methodological consideration 
It is technically challenging to perform high specificity expression profiling of miRNAs due 
to their short length (~ 20 nt), heterogeneous GC content, lack of common sequence features 
(i.e., poly-A-tail), and the fact that the target sequence is present both in the pri-miRNA, the 
pre-miRNA and the mature miRNA (Fig.2) [71]. Also, distinct miRNAs of the same family 
may differ by only a single nucleotide [72]. Below some of these aspects are briefly 
discussed.  
 
4.1.1 Isolation of small non-coding RNAs 
The quality of RNA is important in miRNA microarray- and real-time PCR experiments [73]. 
Small RNA makes up ~0.01 % of all RNAs [72]. Therefore, the direct use of total RNA for 
miRNA assays will limit sensitivity. At the project onset in 2006, there was poor availability 
of commercial miRNA isolation kits. We were, therefore, confronted with the problem of 
isolating RNA enriched with respect to small RNAs. We, consequently, had to combine 
different extraction methods.  
Column-based isolation kits provide binding of small RNA molecules (<200 nt) to a 
silica-based filter in presence of ethanol, e.g., the miRNeasy Mini Kit (Qiagen). However, to 
achieve optimal results with the miRNeasy Mini Kit, miRNA precursors should also be 
removed. Appreciable enrichment can be accomplished using the FlashPAGE Fractionator 
(Applied Biosystems), a device for rapid column gel electrophoresis, which efficiently 
facilitates isolation of small nucleic acids shorter than 40 nt. Unfortunately, this method is 
both relatively costly and time-consuming. On the other hand, in 2006 it did provide an 
efficient alternative to even more time-consuming polyacrylamide gel electrophoresis 
(PAGE) [72].   
Lately, alternative column-based methods for isolation of miRNA enriched fractions, e.g., 
the mirPremier microRNA Isolation Kit (Sigma), have emerged. Unlike the miRNeasy Mini 
Kit, the mirPremier microRNA Isolation Kit yields fractions containing high-purity small 
RNA, essentially without contaminating large RNAs.  
The protocol selected for isolation of RNA for microarray analysis must be chosen with 
the labeling procedure in mind [72]. Indirect labeling procedures usually involve the use of 
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enzymes and are, therefore, sensitive to polluting organic molecules. As a consequence 
phenol-based extractions should not be used. 
 
4.1.2 MicroRNA microarrays 
MicroRNA microarray technology is, as mRNA microarrays, based on nucleic acid 
hybridization between target molecules and their analogous complementary DNA 
oligonucleotide probes [47].  The short length of miRNA makes specific hybridization more 
difficult compared to mRNA. The probes are chosen, not because they possess ideal 
hybridization sequence, but because they are the only available sequences [74]. As individual 
miRNAs have a heterogeneous GC content, the predicted melting temperature (Tm) may span 
a relatively large range. Hence, it is not possible to select optimal probe sequences with 
common melting temperatures or guanine-cytosine content, and this fact can result in non-
optimal hybridization specificity [74]. Therefore, the hybridization temperature is selected to 
achieve a compromise between specificity and sensitivity [46, 47, 72]. MiRNA arrays will, 
consequently, most likely not discriminate between members of miRNA families since their 
sequences are highly homologues [21]. This problem has been addressed using, e.g., control 
spots (negative or positive), spike-in controls or internal controls [72]. Alternatively, LNA 
(locked nuclear acids) probes, which provide higher annealing affinities, are used [47]. 
Further, replicate spotting of the same probe on an array can increase the precision of the 
measurements, and diminish problems caused by random signal noise.  
Microarray assays are based on measurements of fluorescence signals with both a lower 
and an upper detection level [74]. A sample of RNA likely contains a wide range of miRNAs 
concentrations. MiRNA at a low concentration may be found below the threshold level of 
detection, while miRNAs present at very high concentrations may cause saturated 
hybridization signals. It is, therefore, not surprising that different platforms yield somewhat 
different results [74]. It is, consequently, particularly important to establish a lower threshold 
of detection prior to statistical analysis.  
To achieve reliable results, microarray data must be background subtracted and 
normalized before being analyzed for genes that are differentially expressed [72]. 
Normalization is usually performed to remove dye labeling bias and differences in 
hybridization and scanning [72]. However, microarrays should in principle not be used for a 
quantitative measurement, but as a tool to map miRNA expression in two different samples. 
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When establishing a new protocol, a well known sample/tissue can be used to verify 
the method. In our first study we used liver as control tissue. Liver tissue had already been 
screened for miRNAs, several of which had also been verified by an alternative assay [69]. In 
general, microarray data should always be validated by an alternative assay [72]. In our case 
real-time PCR was used. 
In our first study the oligonucleotide microarray  printed at the Microarray Core Facility, 
The Radium Hospital, Oslo, Norway using the mirVana miRNAProbe Set v.1.3 (Ambion Inc., 
TX, USA) was utilized together with the NCode labeling Kit (Invitrogen, CA, USA). These 
microarrays represented a comprehensive selection of human, mouse, and rat miRNAs from 
Sanger miRBase (272 miRNA probes). These were made of amine-modified DNA 
oligonucleotides 42-46 nt long. The probes contained an 18–24 nt sequence that target 
specific known human, mouse, or rat miRNAs, plus spacer and attachment sequences for 
coupling to the surface of the microarray slide. The disadvantage with these arrays is that 
orthologous sequences may be detected. The mirVana miRNA Probe Set also included probes 
targeting an exclusive set of, at the time newly identified, human miRNAs, called Ambi-
miRs. However, signals from these probes were not included in our analysis as we were 
studying murine tissues. All sequences were spotted in triplicates in each array. To validate 
specificity of the hybridization conditions, spike-in controls were used.  
The microarrays from the Microarray Core Facility, The Radium Hospital, Oslo, 
Norway, later became unavailable. We, therefore, switched to Human miRNA OneArray™ 
Microarray v2 printed produced by Phalanx, Palo Alto, CAL., USA, in our third paper. These 
arrays contained 100% of Sanger miRBase v15 miRNA content, e.g. 1087 unique miRNA 
polynucleotide probes. All sequences were printed in triplicates. Probes on these arrays 
contained miRNA-specific sequences and a proprietary spacer designed to enhance the 
hybridization sensitivity to miRNAs. The NCode labeling kit (Invitrogen, CA, USA) could 
not be used in combination with these arrays due to high background labeling. Therefore, the 
ULS (universal linkage system) microRNA labeling kit (Kreatech Amsterdam, Netherlands) 
was utilized. According to the Phalanx hybridization protocol, USL labeled miRNA 
hybridization should be carried out at 37 °C. In our case, however, hybridization at 37 °C 
gave poor hybridization specificity. Therefore, hybridization was carried out at 41 °C. This 
temperature provided high specificity as well as high sensitivity. To validate our microarray 
results we used real-time PCR. 
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The great advantage of microarrays is the ability to measure expression of hundreds of 
genes in one single experiment. However, in the future microarray technology will face 
competition from the latest generation of very high throughput sequencing devices, which are 
predicted to make the microarray technology outdated. With these instruments sequencing of 
the complete miRNA transcriptome in various organisms is possible [48]. This method is not 
hampered by variability in melting temperatures, co expression of nearly identical miRNA 
family members or post-transcriptional modification. 
 
4.1.3 Real-time PCR 
Hybridization procedures may, as mentioned earlier, have limited specificity for mature 
miRNAs. Therefore, real-time PCR is the method of choice for validating microarray results. 
Expression profiling of miRNAs by real-time PCR have four main stages; cDNA synthesis, 
selection of primers (primer design), detection of amplified product and data normalization 
[71].  
cDNA synthesis can be carried out by reverse transcription of miRNAs using stem-loop or 
linear miRNA specific primers, or by tailing RNAs [71]. The specificity and sensitivity of 
real-time PCR assays depend on primer design [46]. Stem-loop primers are designed to bind 
exclusively to the 3’-end of the miRNA. They include a double-stranded part, a loop, and 
short, single-stranded part contain the primer binding sequence [71]. There are several 
advantages to using stem-loop primers: 1) the annealing of a short RT primer to the 3’-portion 
of the miRNA provides improved specificity, 2) the double-stranded stem structure inhibits 
primer binding to pre-miRNAs, 3) the sequence of bases in the stem structure enhances the 
stability of the miRNA-DNA hetro-duplex leading to higher RT efficiency for short primers 
and 4) the unfolded stem-loop structure adds sequences downstream of the miRNA resulting 
in a longer RT-product [75]. We, therefore, utilized stem-loop primers in our studies (Applied 
Biosystems, CA, USA). 
The principle of real-time PCR is based on detection of a fluorescent reporter molecule 
whose signal intensity is proportional to the amount of DNA present [71]. Two technologies 
exist for detection of microRNA using real-time PCR: SYBR Green I and TaqMan probes 
[71]. The TaqMan assay is more specific, as SYBR Green binds all double-stranded cDNA 
while the TaqMan probe binds specifically to the target cDNA sequence. Another 
disadvantage of SYBR Green-based assays is the production of false-positive signals from 
non-specific reaction products, and from primer-dimers or contaminating DNA [71].  
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The TaqMan probe hybridizes to an internal stretch of the amplicon and contains a 
fluorescent reporter and quencher. The close proximity of the fluorescence reporter to its 
quencher molecule prevents emission of the fluorescence. When the Taq polymerase reaches 
the 5’-end of the TaqMan probe, the exonuclease activity of the Taq polymerase hydrolyses 
the probe, and the quencher no longer remains close to the fluorescence reporter [75]. In 
consequence, a fluorescence signal proportional to the amount of PCR product is generated. 
The TaqMan microRNA assays (Applied Biosystems, CA, USA) combine use of stem-loop 
primers for cDNA synthesis and TaqMan PCR, providing specific and sensitive miRNA 
assays. 
All real-time PCR data should be normalized when comparing results from different 
samples. The purpose of normalization is to remove as much technical variation as possible 
between samples [76]. To correct for sample-to-sample variation, e.g., amount of starting 
template and RNA quality, real-time PCR data is commonly normalized to an endogenous 
control (EC) gene. The EC should be stably expressed across all samples analyzed. Also, a 
normalizer molecule should have similar physical and chemical properties to that of miRNAs 
[76]. As the extraction efficiency of miRNA from samples is very different from longer 
RNAs, the normalizer molecule should be selected from a panel of small RNAs. However, an 
miRNA EC suitable for every tissue type and developmental stage has not yet been identified 
[77]. As far as we are aware of, there is no report on the validation of miRNA ECs for 
expression profiling of developing murine tissues. We evaluated several small nucleolar RNA 
genes. But, unfortunately, none of these were found to be consistently expressed (e.g. sno135, 
Applied Biosystems). 
Precise experimental reason for selection of small nucleolar RNA genes as EC, e.g. 
RNU48 and U6, is lacking in a lot of publications. In fact, U6, together with S5, was shown to 
be the two least stable RNA species in a panel of 12 RNA targets evaluated across 13 normal 
human tissues [76]. Therefore, miRNA expression studies utilizing real-time PCR should 
begin with careful selection of appropriate ECs for normalization to ensure accurate 
quantitation. Ideally, a set of controls is chosen for the target cell, tissue, or treatment, as no 
single control can serve as a universal endogenous control for all experimental condition.  
However, the effort, cost, and sample requirements necessary for correct experimental 
selection of miRNA normalizers renders this impractical to achieve. In our mouse 
experiments, we utilized an in-house control to normalize between plates. The in-house 
control entailed the use of RNA from E10 cells (P) and the RNU48 assay.  
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Using the TaqMan method (Applied Biosystems, CA, USA) sample-to-sample variation is 
difficult to control as cDNA synthesis from miRNA and EC is carried out as separate 
reactions. Therefore, normalization against the EC does not directly correlate for the amount 
of starting template, RNA quality or the primer efficiency during cDNA synthesis. 
Nevertheless, we used RNU48 as EC in our cell culture experiments. Our data showed, 
however, that the same relative differences were detected with or without normalization 
against RNU48 suggesting sample to sample variation to be minor.  
The rapid increase in number of miRNAs renders classical real-time PCR inefficient for 
expression profiling, and it is probably best used as a tool for validation.  
 
The miR-17 assay 
With cultured human squamous carcinoma cells, different levels of expression of miR-17 
were reported in paper II and III (higher levels reported in paper III). To investigate possible 
reasons for the discrepancy, various batches of the miR-17 assay-kits (Applied Biosystems) 
were tested using tissues from different stages of development and two carcinoma cell lines 
(E10 and C12). The results indicated that these effects were due to variations between 
different batches of miR-17 assays kits, the more recent batches yielding the higher levels of 
expression. 
 
4.1.4 Experimental design and statistical analysis 
In all mouse experiments tissues/organs from at least three litters or three young adults were 
used. In cell culture studies at least three separate transfections were carried out. Further, all 
biological replicates were analyzed using three technical replicates. Studying expression 
trends a sample size of ≥3 was regarded as adequate. Because of the small samples size, and 
non-normal distribution, the non-parametic Mann-Whitney test was used for analysis of real-
time PCR data. For microarray analysis ANOVA was used [74].  
 
 
 
 
 
 
 
- 36 - 
 
4.2 MicroRNA expression during development  
Since their discovery in the early 1990s, miRNAs have been detected in an extensive range of 
tissues. Also, miRNAs are shown to be involved in almost every aspect of cellular activity 
[78, 79]. It is, therefore, not surprising that our results demonstrate that miRNAs are 
abundantly expressed during development of the murine first molar mandibular tooth germ, 
SMG and liver (Paper I). Numerous studies have demonstrated that miRNAs are essential for 
normal mammalian development [36, 79]. The essential role of miRNA during development 
is supported by the results observed with targeted inactivation of Dicer, which results in loss 
of processed miRNAs and accumulation of miRNA precursors [35]. However, these studies 
do not provide insights into the spatial and temporal expression, or biological functions of 
individual miRNAs. Mapping the expression of miRNAs in different tissues is important for 
understanding how they interact with target mRNAs to form the complex networks that 
regulate development.  
While many miRNAs are ubiquitously expressed, some are expressed in a tissue-
specific manner [31, 80]. Several studies have shown that miRNAs are necessary for proper 
skeletal and cardiac muscle development and function [31]. The muscle specific miR-1, miR-
133 and miR-206 are perhaps the most studied and best-characterized miRNAs to date. 
Studies have revealed that these miRNAs are regulated by myogenic transcription factors. 
The miRNAs may function to “fine-tune” the output of the transcriptional networks, resulting 
in precise cellular responses to developmental needs.  However, even though miR-1 and miR-
133 are specifically expressed in both skeletal muscle and heart, their abundance varies during 
development (reviewed in [31]). Therefore, miRNA profiling of different tissues and organs 
during development, together with functional studies of individual miRNAs, can supply 
essential knowledge concerning their regulatory roles. 
 
4.2.1 MicroRNA expression in the developing murine molar tooth and 
submandibular salivary gland 
In the developing embryo, organs arise from their respective germ cells through reciprocal 
interactions between the epithelium and mesenchyme [81]. This also includes teeth and 
salivary glands [51, 55]. Organ development is strictly controlled by genetic programs which 
regulate morphogenesis, proliferation and cell differentiation [81]. Since miRNAs are thought 
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to regulate up to 50% of all protein-coding genes, they have the potential to assist in the 
countless regulatory mechanisms that occur during development [14]. 
The results from our first paper illustrate that a total of 112 miRNAs are expressed 
during development of murine tooth, SMG and liver. Out of these, 52 are expressed in all 
three tissues, indicating an extensive universal expression of miRNAs (Paper I). However, 
these tissues/organs are relatively heterogeneous, consisting of an extensive range of 
undifferentiated and differentiated cells. The miRNA profile will likely vary between 
different cell types, thus, the results represent the average levels of expression of miRNAs 
expressed in the various cell types in these tissues. 
Our results also indicate that several of the miRNAs detected in tooth, SMG and liver 
are tissue specific (Paper I). However, later studies have revealed that some miRNAs 
considered tissue specific for tooth germ and SMG are also expressed in liver, e.g. miR-200b 
and miR-218 [82, 83]. Also, miR-429, considered tissue-specific in SMG, has later been 
detected in teeth [84]. These observations most likely reflect inadequate sensitivity in 
microarray assays and are, therefore, false-negative results. However, several of the “tissue-
specific” miRNAs were detected at a very low level in their respective tissues, e.g. miR-133a, 
miR-206 and miR-195 in the tooth germ; miR-150, miR-28 and miR-341 in the SMG; and 
miR-381, miR-1 and miR-7 in the liver (Paper I). A relatively low hybridization temperature 
could have yielded high sensitivity but decreased specificity leading to false-positives. As 
miR-133a and miR-1 are described as a muscle-specific miRNA, the latter is more likely [31]. 
Thus, in conclusion, only a few miRNAs appears to truly be tissue-specific. 
MiRNA expression during development is, however, precisely controlled in a time-
dependent manner [80]. Our results show that a total of 31 miRNAs are expressed only during 
development (five of these are expressed only at the day of birth (P0)), whereas three 
miRNAs are expressed exclusively in mature liver. However, only seven of the 31 miRNA 
expressed during development are expressed in all tissues. This observation may indicate 
highly tissue-specific expression of miRNAs during development. 
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The function of microRNAs in murine oral tissues 
 
The miR-200 family and miR-205 
Epithelial mesenchymal transitions (EMT) describe the biological process that facilitates the 
conversion of epithelial cells into cells of a more mesenchymal phenotype, including the loss 
of cell-cell adhesion, loss of cell polarity, and the gaining of migratory and invasive properties 
[85]. EMT, therefore, plays a crucial role during development.  Recent studies have shown 
that the members of the miR-200 family (miR-141, miR-200a, miR-200b, miR-200c and 
miR-429) and miR-205 are essential regulators of differentiation and are expressed in 
epithelial cells [85, 86]. One study demonstrated that EMT is associated with down-regulation 
of miR-205, miR-141, miR-200, and miR-429, suggesting a negative regulatory role of these 
miRNAs on EMT. Induced expression of the miR-200 family in mesenchymal cells promoted 
mesenchymal epithelial transition (MET) [86]. The decreased expression of members of the 
miR-200 family, and miR-205, with EMT is reflected in lower levels of expression of these 
miRNAs in mesenchymal cells compared to epithelial cells [85]. In molar tooth germs miR-
200b and miR-200c were detected and showed increased levels of expression from E15.5 to 
P0 (Paper I). Michon et al. detected the miR-200 family in incisor cervical loop epithelium at 
P5 [84]. In the SMG miR-200c were detected, and showed increased expression during 
development. However, members of the miR-200 family were not detected in liver (Paper I). 
MiR-205 was also detected in tooth germ and SMG, but not in liver. This miRNA exhibited 
increased expression in both tooth germ and SMG between E15.5 and P5. These levels of 
expression were verified using real-time PCR (Paper I). However, miR-205 was detected at a 
very low level in SMG at P25. 
MiR-141 was identified in both tooth germ and SMG, showing increased level of 
expression between E15.5 and P0. In SMG levels of expression of miR-141 was decreased 
between P5 and P25 (Paper I). Because of cross-hybridization, it is not possible to 
discriminate between miR-200b and miR-200c. MiR-200c and miR-141 are transcribed from 
the same cluster [86], and showed similar patterns of expression in the respective tissues, 
although at different levels.  
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The let-7 family 
Members of the let-7 family are highly conserved across species, suggesting that these 
miRNAs possess important regulatory functions. Among this family, let-7a has an identical 
sequence across species ranging from C. elegans to humans. Previously, studies have mapped 
the developmental expression patterns of let-7 in vertebrates, although a direct involvement of 
let-7 in development has not yet been demonstrated. Vertebrate let-7 family members are 
likely to have many roles, and it is technically demanding to knock out all members of the let-
7 family in a single animal. However, an increase in let-7 expression at later developmental 
stages has been reported in many organisms. This increase is consistent with our findings. In 
the murine tooth germ and SMG an increased expression of several members of the let-7 
family is found at later developmental stages (P0, P5 and P25) (Paper I). Let-7 is undetectable 
in human and mouse embryonic stem cells, but the level of let-7 increases in differentiated 
cells. Therefore, it has been proposed that a main role of let-7 is to promote differentiation. A 
relatively high expression of let-7 is sustained in various adult tissues. Conversely, decreased 
expression of let-7 levels has been found in many human cancers, reflective of the reversed 
embryogenesis occurring during tumour genesis (reviewed in [87]). 
 
The function of microRNAs in tooth germ 
In the murine tooth germ, the level of expression of miR-125b is gradually decreased during 
development (Paper I). In a study by Sonkoly et al., miR-125b was expressed in all organs 
studied, but the pattern of expression varied. However, the higher level of expression of miR-
125b was detected in organs containing cells of ectodermal origin [88].  
All members of the miR-199a/miR-214 cluster were detected in the murine tooth 
germ; i.e., miR-199a_3p, miR199a_5p and miR-214. Together with miR-125b, miR-214 and 
miR-199a_5p (miR-199a_AS) exhibited the higher levels of expression in tooth germ (Paper 
I). The expression of miR-214 was also verified using real-time PCR (Paper I).  
In a study by Sehic et al. miR-214 were silenced in vivo in mouse tooth germ using 
anti-miR-214 [89]. The results illustrated that injection of anti-miR-214 altered the expression 
of seven other miRNAs including miR-199a_5p and miR-199a_3p. While the level of 
expression of miR-214 was significantly decreased, the level of expression of miR-199a_3p 
and miR-199a_5p were increased. The authors suggested that inactivation of miR-214 
stimulated transcription of the miR-199a/miR-214 primary transcript. In anti-miR-214-treated 
molars the enamel showed evidence of hypomineralization, likely due to the decreased 
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expression of Amelx and Enam, encoding enamel matrix proteins [90]. In a study by Michon 
et al. conditional deletion of Dicer-1 in the epithelium resulted in a mildly abnormal tooth 
shape and enamel [84]. These results suggested that miRNA modulates tooth morphogenesis 
and ameloblast differentiation, possibly by fine-tuning signaling networks. 
In another study by Sehic et al., the miRNA expression profile of the murine maxillary 
incisor tooth germ was screened at P0 and P10 using microarrays [91]. Comparing these 
results to our first paper shows that 16 of the miRNAs detected in maxillary incisor is also 
detected in first mandibular molar at P0 (Paper I). However, the majority of the miRNAs 
detected by Sehic et al. were not present on the miRVana v1.3 arrays (Ambion). On the other 
hand, while Sehic et al. utilized only the incisal part of the incisor, we used the whole first 
molar tooth germ. Therefore, it is impossible to perfectly compare the miRNA expression in 
these studies. On the other hand, the continuously growing incisor exhibits all stages of tooth 
formation along its inciso-apical axis. For instance, at P0, enamel matrix secretion has started 
in both the incisor and the first molar, indicating the same processes to be active in both tooth 
germs at this stage [92]. Our results were also confirmed by Cao et al., in that study miRNAs 
were shown to control tooth epithelial stem cell differentiation [93]. 
 
The function of microRNAs in the SMG 
We are aware of only two published reports on miRNA expression in murine SMG. In 
addition to our study, a study by Hayashi et al. show that miR-21 are involved in branching 
morphogenesis of the murine SMG  in vitro at E13.5 [94]. Our results show that miR-21 is 
also present in the SMG at E15.5, P0, P5 and P25 (Paper I). Moreover, Hayashi et al. detected 
43 other miRNAs at E13.5, 26 of which were also detected in our study at one or more of the 
time-points investigated. Several of the miRNAs sequences detected by Hayashi et al. in the 
SMG were, however, not present on the miRVana v1.3 microarrays. 
In general, our results indicate that miRNAs play important roles during murine SMG 
and tooth development. However, methods capable of unraveling events occurring in a single 
cell, or a small group of cells, will prove useful in future studies, e.g., in situ hybridization 
[95], or laze dissection studies. 
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4.2.2 Expression of the miR-17-92 cluster in developing murine tissues 
To date, the miR-17-92 cluster is one of the best-characterized miRNA clusters [57]. Several 
members of the miR-17-92 cluster (miR-17, miR-18, miR-19a, miR-19b and miR-20) were 
identified in 2001 by Lagos-Quintana et al [96]. In 2002, Mourelatos reported that also miR-
92a is encoded by the cluster [97].  
In 2005, Hayashita et al. found the miR-17-92 cluster to be over-expressed in lung 
cancer [98]. Later, several reports have shown that miR-17-92 plays an important role during 
lung development [38, 99]. Members of the miR-17-92 cluster are among the more highly 
expressed miRNAs in mouse developing lung. Three members of the cluster: miR-17, miR-
19b and miR-20a are present both in epithelium and mesenchyme of the embryonic lung 
[100]. The miR-17-92 cluster is also highly expressed in endothelial cells [101, 102], and 
contributes to development of heart and blood vessels [59, 62, 65]. We have shown that the 
miR-17-92 cluster is also abundantly expressed in the developing murine tooth, SMG and 
liver (Paper I).  
In the developing lung, levels of expression of all members of the cluster have been 
found to gradually decline until they are barely detectable in the adult lung [38]. A similar 
trend was observed with developing murine tooth, SMG and liver (Paper I). In these tissues 
the members of the cluster are highly expressed at an embryonic stage, while their levels are 
diminished at postnatal- and young adult stages. 
To provide an insight into the temporal expression of the members of the miR-17-92 
cluster in different tissues, microarray data were validated and extended to additional 
developmental stages and tissues using real-time PCR (Paper II). The results show that also in 
murine skin, cerebral hemisphere, small intestine, kidney and heart, the members of the miR-
17-92 cluster show higher level of expression at early embryonic stages compared to young 
adult stages. Therefore, the miR-17-92 cluster may be important for the development of 
phenotypically diverse tissues.  
 
Functions of the miR-17-92 cluster 
Results have suggested that miR-17-92 promotes proliferation of undifferentiated lung 
epithelial progenitor cells [38]. In the liver, all members of the miR-17-92 cluster were shown 
to have consistently higher level of expression at embryonic stages compared to postnatal 
stages (Paper I and II). The lower level of expression was found at P25. The expression of 
miR-122, a highly abundant, liver-specific miRNA, increases during development and the 
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higher level of expression of this miRNA is found in the fully developed liver [103]. These 
findings suggest that the expression of tissue-specific miRNAs increases as cells achieve their 
final identity. In parallel, expression of the members of the miR-17-92 cluster is decreased. 
These findings support the idea that members of the miR-17-92 cluster are highly expressed 
in proliferating, undifferentiated cells, where they may serve to maintain high rates of 
proliferation and likely suppress differentiation [59, 63].     
To further investigate possible involvement of the miR-17-92 cluster in proliferation, we 
decided to measure the levels of expression of all members of the cluster at selected passages 
of cultured primary oral keratinocytes. A consistent decrease in levels of expression of all 
miRNAs was observed at the higher cell passage number for two out of three studied cultures, 
while the level of expression of miR-17, miR-19a, miR-19b, miR-20a and miR-92a were 
unchanged at the higher cell passage number in the third culture (Paper II). These results 
likely reflect biological variation as the keratinocyte cultures are derived from separate 
donors. However, the results indicate that the miR-17-92 cluster indeed promotes cell 
proliferation and show decreased expression in differentiated cells. Keratinocytes has been 
shown to differentiate in culture [104]. 
Carraro et al. have shown that miR-17, miR-20a and miR-106b (a member of the miR-
106b-25 cluster) are involved in lung branching morphogenesis [99]. These miRNAs regulate 
translation of Mapk14 and Stat3. Over-expression of miR-17 was shown to cause increased 
cell proliferation. Cloonan et al. suggested that miR-17 has the ability to regulate cell cycle at 
the G1/S check point [105], and thereby, increasing rate of proliferation. 
 
Interactions between the miR-17-92 cluster and transcriptionfactores MYC and E2F  
MiRNA clusters produce multiple miRNAs from one single primary transcript and each of 
these may function independently. Therefore, cluster-derived miRNA may regulate numerous 
genes, making them important regulators of the complex molecular network controlling 
development [57]. The miR-17-92 encoding six miRNAs may, therefore, have an appreciable 
regulatory potential. So far, several targets of the miR-17-92 cluster have been verified [61]. 
MiRNAs encoded in the miR-17-92 cluster can be divided into four families (Fig.3). 
Interestingly, miRNAs belonging to the same family exhibit different levels of expression 
(Paper II). Therefore, members of the same miRNA family may have different functions, even 
though they have identical “seed” sequences and, therefore, should potentially have shared 
targets.  
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The functions of miRNAs are context-dependent, meaning that the function of a miRNA 
will depend on composition of the transcriptome, which will vary between different cell types 
[57, 106]. As a single miRNA can have several targets, its function will depend on the mRNA 
profile. The fact that the expression of miRNAs can be regulated via several other genes adds 
further to their regulatory complexity. 
An interesting regulatory feedback loop exists between miR-17-92 and E2F (Fig. 5). Two 
members of the miR-17-92 cluster, miR-17 and miR-20, are known to repress the cell cycle 
regulator E2F1. On the other hand, E2F1 has been shown to activate transcription of the miR-
17-92 cluster. E2F1 is one of the main drivers of the G1/S transition during the cell cycle. The 
miR-17-92 cluster is also transcriptionally activated by the proto-oncogene c-Myc.  Since c-
Myc also promotes E2F1 transcription it is likely that c-Myc fine-tune cell cycle progression 
via regulation of both miRNA and mRNA expression (reviewed in [63]). Control of the miR-
17-92 cluster by E2F and c-Myc likely play an important role in cell proliferation during 
development. 
 
4.2.3 Expression of the miR-106a-363 and miR-106b-25 clusters in 
developing murine tissues 
The miRNA microarray results from our first paper may contain false positives due to a 10% 
mismatch. Therefore, considering the sequence similarities of the members of the miR-17-92, 
miR-106a-363 and miR-106b-25 clusters, there is a high probability that some of the mature 
paralogous miRNAs will bind to the same probe, e.g. miR-20a and miR-20b (Fig. 3). As a 
consequence, microarray results indicate that all members of the miR-17-92 and miR-106b-25 
clusters are expressed at one or more of the developmental stages investigated (Paper I). 
Based on these assumptions, all members of the miR-106a-363 cluster, except for miR-363, 
are also expressed in the developing tissues (Paper I). The probe for miR-363 was not present 
on the miRVana arrays. However, several studies have shown that while the miR-17-92 and 
miR-106b-25 clusters are expressed in several different tissues, expression of the miR-106a-
363 cluster have not been detected [59]. Therefore, detected members of the miR-106a-363 
cluster may be due to cross-hybridization because of paralogous miRNA sequences in the 
miR-17-92 and miR-106b-25 clusters.  
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4.3 Expression of the miR-17-92, miR-106a-363 and miR-
106b-25 clusters in cultured human squamous carcinoma 
cells 
All members of the miR-17-92 cluster are expressed in cultured human squamous carcinoma 
cells (Paper II and III), although levels of expression of individual members vary. However, 
the results show that levels of all miRNAs encoded in the cluster increases with increasing 
number of cell passages (Paper II). These results contrast findings obtained with both 
developing murine tissues and cultured differentiating human oral keratinocytes (Paper I and 
II). However, in carcinoma cells, no increase in level of expression of the primary transcript 
was observed. Therefore, the elevated level of the mature miRNAs in later passages is likely 
caused by diminished degradation of the transcript.  
Members of the miR-106b-25 cluster were also identified in cultured squamous 
carcinoma cells (Paper III). The level of expression of miRNAs encoded in this cluster also 
differed as we found that miR-93, miR-106b, and miR-25, were expressed at a low-, 
intermediate- and high level, respectively (Paper III). This result show that also in cultured 
squamous carcinoma cells the level of expression of mature miRNAs encoded in clusters is 
likely regulated post-transcriptionally. 
In squamous carcinoma cells, four members of the miR-106a-363 cluster were 
detectable: miR-106a, miR-19b, miR-20b and miR-92a. However, miR-19b and miR-92a may 
originate from the miR-17-92 cluster. Therefore, miR-106a and miR-20b may be the only 
miRNAs derived from the miR-106a-363 cluster. The level of expression of miR-20b was, 
however, barely detectable. These results indicate that a polycistronic cluster, consisting of 
six potential miRNA, may give rise to a single functional, mature miRNA. 
 
4.3.1 A possible role for miR-363* 
Processing of the miRNA hairpin precursors (pre-miRNA) give rise to a double stranded 
small RNA duplex (~ 22 nt) (Fig. 2). Although both stands of the pre-miRNA duplex are 
produced in identical amounts, their accumulation is asymmetric (Fig. 5). Based on the 
thermodynamic stability of each end of this duplex, one of the stands is regarded as the 
biologically active miRNA. The other is considered as an inactive strand, called the miRNA* 
or passenger strand. Generally, the biological active strand of the duplex is selected for entry 
into the RISC complex [107], while the passenger strand is degraded. 
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  However, recently, some miRNA* sequences were reported as mature functional 
miRNAs with abundant expression [70]. Also the miRNA/miRNA* ratio may vary 
dramatically between developmental stages [14, 107]. Interestingly, miRNA profiling of 
cultured human oral keratinocytes showed appreciable expression of miR-363*, a member of 
the miR-106a-363 cluster (and the star strand species of miR-363). However, in cultured 
human squamous cancinoma cells (E10) the expression of miR-363* was barely detectable. 
Considering this observation, and the fact that the miRNA* species is generally regarded as a 
passenger RNA [70], the function of which has not been examined in vertebrates, we decided 
to investigate the effects of miR-363* by transfection with miR-363* mimic in E10 cells. 
Transfection with miR-363* mimic in E10 cells led to decreased cell proliferation and 
decreased level of expression of the miR-17-92 and miR-106b-25 clusters (Paper III). As 
miRNAs encoded in these clusters show high levels of expression in proliferating cells [63], 
the observed decline in level of expression of these miRNAs are consistent with the observed 
decrease in the number of cells. The decreased expression of miRNAs encoded in the miR-
17-92 and miR-106b-25 clusters may cause diminished proliferation. However, as expression 
of the miR-17-92 and miR-106b-25 clusters are regulated by proteins regulating cell cycle, 
e.g. E2F and c-MYC, the decreased expression of these clusters, and the diminished cellular 
proliferation, may be caused by altered cellular level of such proteins.  
Decreased cellular proliferation was also observed in cells transfected with miR-20b 
mimic (Paper III). The miRNA expression profiles were, however, markedly different. 
Therefore, miRNA-mediated mechanisms inhibiting cellular proliferation are likely also 
different. 
 
 
 
 
 
 
 
 
 
 
 
- 46 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Selection of the mature functional miRNA strand.  The mature functional miRNA strand is 
generated from either the miR strand or miR* (star) strand. The passenger stand is degraded. Both the 
miR and miR* strand are potential mature miRNA sequences. 
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4.4 Regulation of transcription of genes encoding 
microRNA clusters 
Nearly half of the loci for mammalian miRNAs are closely located, often in clusters, with a 
“master” promoter for the production of a single polycistronic transcription unit [9, 11]. 
Transcription of these miRNA clusters is probably strictly regulated.  
Most pri-miRNAs are transcribed by RNA Poly II and contain the 7-methylguanylate cap 
at the 5’-end and a poly (A) tail at the 3’-end, a trait also characteristic of mRNAs [15]. Since 
most miRNA encoding genes are transcribed by RNAPII, they are believed to share the 
regulatory mechanisms of protein encoding genes. Promoters of miRNA encoding genes have 
regulatory sequences analogues to those of protein encoding genes, e.g., relative frequencies 
of CpG islands, TATA box, TFIIB recognition elements and initiator elements [9]. DNA-
binding factors that regulate transcription of miRNA encoding genes are also similar to those 
controlling protein encoding genes. However, the transcriptional regulation of miRNA 
clusters is less readily studied because promoter regions of ncRNAs are often difficult to 
identify [9].   
Since paralogous clusters are located on different chromosomes and produce separate 
transcripts, their transcription may be independently regulated. Consequently, functional 
differences between such clusters could be due to separate regulatory mechanisms. Therefore, 
paralogous miRNA clusters exhibiting non-synchronous expression may be subjected to 
independent regulation of transcription. However, some paralogous miRNA clusters on 
different chromosomes exhibit synchronous expression. These miRNA clusters may, 
therefore, have synchronous regulatory schemes and may consequently function in a 
cooperative manner (reviewed in [10]). In fact, Kim et al. reported that separate clusters can 
be co-expressed and have related functions [108].  
Both the primary transcript and all mature members of the miR-17-92 cluster were 
detected in the developing murine tooth, SMG and liver (Paper II). Also, several members of 
the miR-106a-363 and miR-106b-25 clusters were detected in all tissues (Paper I). However, 
as mentioned earlier, the detection of members of the miR-106a-363 cluster may be due to 
cross-hybridization. In human squamous carcinoma cells the primary transcript and all mature 
members of the miR-17-92 and miR-106b-25 clusters were detected using real-time PCR, 
while miR-106a was the only detectable member of the miR-106a-363 cluster (Paper III). The 
miR-106-363 primary transcript was undetectable. Therefore, the miR-17-92 and the miR-
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106b-25 clusters may by regulated by similar transcriptional elements, while the miR-106a-
363 cluster is subject to a separate regulatory scheme. As previously discussed, transcription 
of the miR-17-92 is regulated by MYC and E2F.  The miR-106b-25 cluster is also activated 
by E2F and MYC in parallel with its host gene, MCM7 [66, 109]. In turn, miR-17, miR-20a, 
miR-106b and miR-93 regulate expression of E2F, establishing a negative feedback loop (Fig. 
5). However, expression of all three clusters are repressed by p53 [63]. 
Tanzer et al. described a duplication-degeneration-complementation model for the 
evolution of the miR-17-92 cluster which predicts that after gene duplication either one of the 
two paralogs is lost [13]. If both are retained, the two paralogs will evolve to perform 
complementary functions. The model further predicts that duplicate clusters containing 
redundant miRNAs should differ in their spatial and temporal pattern of expression.  
We also observed a strong correlation between the level of expression of the primary 
transcript and the level of mature miRNAs. This relationship indicates that regulation of 
transcription is one mechanism regulating the level of the mature miRNA. Post-transcriptional 
regulation may serve to fine-tune the level of individual miRNAs. 
Transfection with miR-363* mimic in cultured, human squamous carcinoma cells caused 
diminished expression of all members of the miR-17-92 and miR-106b-25 clusters. However, 
the level of expression of the respective primary transcripts was also decreased. These 
observations indicate that the miR-363*, a member of a paralogous cluster, can directly or 
indirectly regulate transcription of the miR-17-92 and miR-106b-25 clusters.  
However, in cells transfected with miR-19a, miR-20b or miR-92a, correlation between the 
level of expression of the miR-17-92 and miR-106b-25 primary transcripts and the level of 
expression of their respective members were not found. While the levels of expression of the 
primary transcripts were increased, the levels of expression of some mature members were 
decreased. Consequently, our results show that cellular levels of miRNAs are regulated at two 
levels; transcriptionally and post-transcriptionally. 
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Fig.5 Summary of the interactions among the transcription factors Myc and E2F, and members of the 
miR-17-92 and miR-106b-25 clusters. All arrows indicate induction of gene expression. The 
hammerheads from miR-17, miR-20a, miR-106b and miR-93 to E2F indicate inhibition of translation 
or degradation of the mRNA. 
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4.5 Processing of polycistronic microRNAs into mature 
microRNAs 
From the initial transcription of miRNA encoded genes in the nucleus to the synthesis of 
mature miRNA in the cytoplasm, their production may be subject to regulation at several 
levels. Both transcriptional and post-transcriptional mechanisms are likely involved [14].  
Although miRNAs encoded in the miR-17-92 cluster are derived from a single 
polycistronic transcript,  Lu et al. found that levels of expression of individual members of the 
miR-17-92 cluster vary in the developing lung [38]. In developing murine liver, SMG, tooth, 
skin, cerebral hemisphere, small intestine, kidney and heart, differences in levels of 
expression of members of the miR-17-92 cluster were also observed (Paper II). These 
findings indicate that levels of expression of the miRNAs encoded in the miR-17-92 cluster 
are regulated post-transcriptionally. Analogous results were found for miRNAs encoded in the 
miR-17-92 and miR-106b-25 clusters in cultured human squamous carcinoma cells (Paper II 
and III).  
Our results show strong correlation between pattern of the expression of primary 
transcripts and the pattern of expression of the mature miRNAs (Paper II). Further, no 
difference in levels of expression between the 5’-end and the 3’-end of the transcript were 
found in the developing tissues, therefore, the proportional difference between the members 
of a miRNA cluster is most likely caused by post-transcriptional regulatory mechanisms. 
However, in human squamous carcinoma cells a significant difference between the 5’-end and 
the 3’-end of the transcript was found (Paper III). The assays based on the 3- end constantly 
showed much higher levels of expression. These findings suggest the 5’-end to be less stable 
than the 3’-end transcript. 
The level of mature miRNAs encoded by the same cluster may result from differential 
processing in the nucleus by Drocha, selective transport into the cytoplasm by Expotin-5, or 
discriminating processing by Dicer in the cytoplasm (Fig. 3). Actually, RNA editing of 
several pri-miRNAs by ADAR (adenosine deaminase acting on RNA) can affect both Drocha 
and Dicer-mediated cleavage, leading to modification of sequence information causing altered 
miRNA processing efficiency [14].  
Several reports have identified proteins that regulate processing either by interacting 
with Drocha or Dicer or by binding to the pri- or pre-miRNA [14]. As processing into mature 
miRNAs require binding of specific cofactors, the RNA sequences surrounding the miRNA, 
 
 
- 51 - 
 
e.g. stem-loop sequences, may be significant for processing of individual cluster-encoded 
miRNAs.  
The activity of some of the regulatory cofactors is limited to specific miRNA families. 
For example, hnRNP A1, a multifunctional RNA-binding protein,  binds specifically to the 
primary RNA sequence of pri-miR-18a before Drocha processing, indicating that cluster-
encoded miRNAs undergo specific processing [110]. However, selection among family 
members may also take place as these are detected at different levels, e.g., miR-17 and miR-
20a (Paper II and III).  
Tertiary folding of the pri-miRNA transcripts may also regulate processing of 
clustered miRNAs. The consequence can be variable efficiency as regards processing of 
different regions of the primary transcript. 
In conclusion, the processing of miRNAs derived from a single initial transcript is still 
poorly understood. 
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5 Conclusions 
 
MicroRNA expression in developing murine tissues: 
 MicroRNAs are abundantly expressed in murine first molar mandibular tooth germ 
and murine submandibular salivary gland, and their expression is highly dynamic; the 
miRNA profile changes extensively with time of development. Bioinformatics 
analysis suggests that miRNAs are “fine-tuning” the activity/quantity of mRNAs 
expressed during organogenesis. 
 
Functional role of the miR-17-92 cluster: 
 The levels of expression of microRNAs encoded in the miR-17-92 cluster are 
consistently higher at early stages of development in phenotypically very different 
tissues.  
 
 The level of expression of microRNAs encoded in the miR-17-92 cluster in cultured 
human oral kerationocytes at different passages may reflect ongoing keratinocyte 
differentiation. 
 
Regulation and processing of microRNA clusters: 
 Individual mature constituents of the miR-17-92 cluster exhibit different levels of 
expression in murine tissues, in cultured oral human keratinocytes and in cultured 
human squamous carcinoma cells, indicating post-transcriptional regulation of these 
miRNAs. Analogous results were found with members of the miR-106b-25 cluster in 
cultured human squamous carcinoma cells. 
 
 In murine tissues, the expression pattern of the miR-17-92 primary transcript 
correlates with expression of the matured microRNAs encoded in the cluster. Post-
transcriptional regulation may, therefore, be regarded as “fine-tuning” of levels of 
expression of individual miRNAs. 
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Functional role of miR-363*: 
 Cultured human squamous carcinoma cells transfected with miR-363* mimic 
exhibited significantly decreased proliferation, and decreased expression of the miR-
17-92 and miR-106b-25 primary transcripts and of all miRNAs encoded in these 
clusters. Therefore, levels of expression of polycistronically encoded miRNAs are 
influenced by the cellular level of a miRNA encoded by a paralogous gene. Moreover, 
miRNA*-species are likely functional and, thus, contribute to the miRNA regulatory 
network. 
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6 Future perspectives 
Despite appreciable accumulation of knowledge concerning miRNAs during the last few 
years, information regarding function of miRNA during development is limited. Expression 
profiling has shown that these small RNAs are widely expressed in developing tissues/organs. 
However, most miRNA targets have not been experimentally verified. Therefore, improved 
experimental techniques enabling direct verification of targets are needed. Also, techniques 
suited to explore the impact of miRNAs on protein output is required, e.g. proteomics 
technology [111]. It is also important to study miRNA-mRNA interactions in a cellular 
context, as the relationship between miRNA and a target found in one type of cell may not be 
valid in another type of cell. 
Our understanding of regulation of miRNA biogenesis is limited, especially biogenesis 
of clustered miRNAs. Therefore, studies focusing on regulation of expression of miRNA 
clusters and processing of their constituent miRNAs are important.  
So far most work with miRNAs has focused on the role of individual miRNAs as 
regulators of translation. It is seems relevant also to study regulatory effects of combinations 
of miRNAs. MiRNAs encoded in a cluster are a likely candidate for such studies. Further, 
studies of concerted effects of miRNAs are essential if the therapeutic potential of miRNAs is 
to be exploited. 
To further increase our understanding of miRNAs in developing murine tissues and 
the function of miRNAs encoded in the miR-17-92, miR-106a-363 and miR-106b-25 clusters, 
the following studies may be carried out: 
 
 Elucidation of cellular locations of candidate miRNAs in developing murine 
molar tooth germ or submandibular salivary gland (in situ hybridization) 
 Transfection or co-transfection of cells with miRNA mimics for remaining 
members of the miR-17-92, miR-106a-363 or miR-106b-25 clusters 
 Transfection of cells with anti-miRNAs against miRNAs encoded in the miR-
17-92, miR-106a-363 or miR-106b-25 clusters 
 Screening the mRNA profile in cells transfected with miRNA mimics or anti-
miRNAs to identify potential targets (microarrays). Such studies should be 
combined with appropriate methods, e.g., Western-blotting, to monitor changes 
in levels of proteins.  
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